Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05685589
Other study ID # 00016672
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 4, 2023
Est. completion date July 2024

Study information

Verified date November 2023
Source Southwest Autism Research & Resource Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project will evaluate the effectiveness of MINDful TIME, an 8-week mindfulness-based program designed to improve mental health in adolescents with autism spectrum disorder and their caregivers. MINDful TIME includes weekly psychoeducational group meetings conducted through videoconferencing and use of a commercially available mindfulness meditation app. The investigators predict that adolescents in the mindfulness intervention group will demonstrate increases in self-reported mindfulness and reductions in self- and parent-reported anxiety and depression relative to a delayed treatment control group. The investigators will also explore whether caregivers in the treatment group demonstrate improvements in quality of life.


Description:

Interested individuals and their parent/caregiver who meet preliminary eligibility criteria during the phone screen will be scheduled for a 1-2 hour virtual study visit to complete an intake interview for study and a brief IQ test. If individuals have completed this assessment at SARRC within the last five years, they will not be re-assessed; however, they will complete a 30-minute virtual intake visit to complete the intake interview, learn about the intervention and determine if they would like to participate. Participants in the treatment group will complete three virtual study visits (Baseline, intervention exit, 2-month follow-up), whereas participants in the delayed treatment control group will complete four virtual study visits (Baseline, wait for the period exit, intervention exit, 2 month-follow-up). After completing their second-time point (i.e., wait period exit) participants in the delayed treatment control group will be enrolled in the 8-week intervention. The investigators anticipate that the duration of an individual participant's participation in the study from baseline data collection to study completion will be approximately 6 months. Participants may be enrolled up to 8 months prior to their baseline data collection depending on when they are recruited into the study and whether they participate in cohort 1 or cohort 2.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date July 2024
Est. primary completion date January 23, 2024
Accepts healthy volunteers No
Gender All
Age group 13 Years to 18 Years
Eligibility Inclusion Criteria: - Adolescents must be ages 13 to 18 years - Formal clinical or educational ASD diagnosis confirmed by the study team (i.e., review of the formal diagnostic or educational report) - Must be willing to be randomized to a treatment or delayed treatment control group - Must be able to attend at least 7 of the 8 group meetings - English speaking: Adolescents and their parent/caregivers must be English-speaking because the screening and behavioral measures are in English, as well as the intervention content - Participants must live in the state of Arizona, USA Exclusion Criteria: - Non-verbal participants will be excluded to ensure test compliance and increase sample homogeneity. - Participants with IQ scores <70 will be excluded because the intervention was developed for individuals without intellectual disabilities. - Participants with a physical disability or co-occurring condition that may prevent participation in the weekly group meetings (e.g., selective mutism; aggressive behavior; inability to participate in a 90-minute video conference meeting each week) - Participants who report active suicidal ideation

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
MINDful TIME
The intervention will include weekly 90-minute group meetings held online through Zoom. Adolescents and parents will meet in separate groups and will learn about mindfulness-based strategies that can be used to manage and reduce stress, anxiety, and depression. They will also learn evidence-based strategies to complete daily guided mindfulness meditations using Ten Percent Happier, a commercially-available mobile app. Participants will be encouraged to meditate using the mobile app for at least 10 minutes each day during and after the 8-week intervention.

Locations

Country Name City State
United States Southwest Autism Research and Resource Center Phoenix Arizona

Sponsors (3)

Lead Sponsor Collaborator
Southwest Autism Research & Resource Center Arizona State University, Blue Cross Blue Shield of Arizona Foundation for Community and Health Advancement

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Change from Baseline in Children's Depression Inventory (CDI) Scores Parent-report measure of adolescent depressive symptoms. Scores range from 30 to 90 with higher scores indicating higher levels of depression symptoms. Post-intervention (8 weeks); 2-month follow-up
Primary Mean Change from Baseline in Multidimensional Anxiety Scale for Children (MASC) Scores Parent-report measure of adolescent anxiety symptoms. Scores range from 30 to 90 with higher scores indicating higher levels of anxiety symptoms. Post-intervention (8 weeks); 2-month follow-up
Primary Mean Change from Baseline in Child and Adolescent Mindfulness Measure (CAMM) Scores Adolescent-report measure of mindfulness. Scores range from 0 to 40 with higher scores indicating higher levels of mindfulness. Post-intervention (8 weeks); 2-month follow-up
Secondary Mean Change from Baseline in Beck Youth Inventories (BYI) Scores Adolescent-report measure of depression. Scores range from 0 to 90, with higher scores indicating higher levels of depression. Post-intervention (8 weeks); 2-month follow-up
Secondary Mean Change from Baseline in World Health Organization-Five Wellbeing Index (WHO-5) Scores Adolescent-report measure on current well-being. Scores range from 0 to 100, with higher scores indicating better quality of life. Post-intervention (8 weeks); 2-month follow-up
Secondary Mean Change from Baseline in Adaptive Behavior Assessment System (ABAS-3) Scores Parent-report measure of adolescent adaptive skills across the lifespan. Scores range from 40 to 120, with higher scores indicating better adaptive skills. Post-intervention (8 weeks); 2-month follow-up
Secondary Mean Change from Baseline in Social Responsiveness Scale (SRS-2) Scores Parent-report measure of adolescent presence and severity of social impairment within autism spectrum. Post-intervention (8 weeks); 2-month follow-up
Secondary Mean Change from Baseline in Behavior Rating Inventory of Executive Function (BRIEF) Scores Parent-report measure of adolescent executive function and self-regulation. Scores range from 30 to 90, with higher scores indicating higher levels of executive dysfunction. Post-intervention (8 weeks); 2-month follow-up
Secondary Mean Change from Baseline in Five Facets Mindfulness Questionnaire (FFMQ) Scores Adolescent-report measure of mindfulness on observation, description, aware actions, non-judgmental inner experience, and non-reactivity. Factor scores range from 1 to 5, with higher scores indicating higher levels of mindfulness. Post-intervention (8 weeks); 2-month follow-up
Secondary Mean Change from Baseline in Family Quality of Life Scale (FQOL) Scores Parent-report measure of family quality of life in family interaction, parenting, emotional well-being, physical/material well-being, and disability-related support. Scores range from 1 to 5, with higher scores indicating higher satisfaction with family quality of life. Post-intervention (8 weeks); 2-month follow-up
Secondary Mean Change from Baseline in Stress Index for Parents of Adolescents (SIPA) Scores Parent-report measure of the relationship of parenting stress to adolescent characteristics, parent characteristics, the quality of the adolescent-parent interactions, and stressful life circumstances. Percentile scores range from 0 to 99, with higher scores indicating higher levels of parenting stress. Post-intervention (8 weeks); 2-month follow-up
See also
  Status Clinical Trial Phase
Completed NCT05207956 - App for Strengthening Services In Specialized Therapeutic Support N/A
Completed NCT03286621 - Development of Eye-tracking Based Markers for Autism in Young Children
Completed NCT02608333 - Efficiency of Early Intervention for Autism Spectrum Disorder N/A
Recruiting NCT05935722 - Evaluation of a Home-based Parenting Support Program: Parenting Young Children N/A
Active, not recruiting NCT06259539 - A YouTube Curriculum for Children With Autism and Obesity N/A
Active, not recruiting NCT06303791 - Digital-based Psychosocial Intervention for Parents of Children With Neurodevelopmental Disorders N/A
Enrolling by invitation NCT05017779 - A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth N/A
Completed NCT04772898 - Effectiveness of a 6-week Hippotherapy Program in Children With Autism Spectrum Disorder N/A
Recruiting NCT04987541 - The Therapeutic Effect of TBS Stimulation on Emotion Regulation in Autism Spectrum Disorder N/A
Completed NCT04308915 - Mobile-based Games for Cognitive Training in Children With Neurodevelopmental Disorders N/A
Completed NCT06038435 - The Effect of Cognitive Orientation Approach on Daily Occupational Performance With Autism Spectrum Disorder N/A
Terminated NCT04049981 - Investigation of Mechanisms of Action in Superpower Glass Phase 1/Phase 2
Completed NCT03693313 - The Effect of CrossFit Kids on Social Skills in Children With Autism Spectrum Disorder (CrossFit KAMP) N/A
Recruiting NCT04107064 - Achieving Steady Work Among Adults With Autism Through Specialized Employment Program N/A
Recruiting NCT03812068 - Parent-mediated Developmental Behavioral Intervention N/A
Completed NCT03206996 - Exposure Therapy for Auditory Sensitivity in Autism N/A
Completed NCT02299700 - Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder N/A
Completed NCT03422016 - Electroretinogram in Autistic Spectrum Disorders
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Recruiting NCT05114538 - Improving the Part C Early Intervention Service Delivery System for Children With ASD N/A